̽»¨¾«Ñ¡

Professor of Glial Cell Biology at ̽»¨¾«Ñ¡ (KI), Stockholm, Sweden

Distinguished Professor of the Swedish Research Council within Medicine and Health

Wallenberg Scholar

Deputy Head and Chair of the Senate of the Department of Medical Biochemistry and Biophysics 

Member of the Nobel Assembly at ̽»¨¾«Ñ¡

Gonçalo Castelo Branco was born in Cantanhede, Portugal, in 1976. He is educated in Biochemistry at the University of Coimbra with a B.Sc.. degree in 1999 and defended his PhD at KI in 2005. He did postdocs at KI 2005-2008 and at the Gurdon Institute, University of Cambridge, Great Britain, 2009-2012. Gonçalo Castelo Branco started his research group at KI in 2012. He became a docent (associate professor) in 2016. In 2019 he was awarded the Swedish Society for Medical Research Jubilee Prize and in 2021 with both the Göran Gustafsson Prize in Medicine and the Eric K Fernström Prize for young, particularly promising and successful researchers, and he was elected to the Nobel Assembly at ̽»¨¾«Ñ¡ in 2023.. Gonçalo Castelo Branco is Professor of Glial Cell Biology at ̽»¨¾«Ñ¡ since 1 November 2021.

Main interests: Single cell and spatial transcriptomics and epigenomics, oligodendroglia, remyelination, multiple sclerosis, neuroimmunology

Education
Associate Professor (Docent), ̽»¨¾«Ñ¡, Stockholm, Sweden
Post-doctoral fellow, The Gurdon Institute, University of Cambridge, United Kingdom
Post-doctoral fellow, Department of Neuroscience, ̽»¨¾«Ñ¡, Sweden, Hermanson's lab
PhD, Medical Biochemistry, ̽»¨¾«Ñ¡, Sweden,
B.Sc., Biochemistry, University of Coimbra, Portugal, B.Sc. student at Saraiva's lab, , Portugal

Academic honours, awards and prizes
2023- Member of
2022
2021
2021
2019

Our research group is interested in the molecular mechanisms defining the epigenetic state of oligodendrocyte lineage cells. We are particularly focused on how interplay between transcription factors, non-coding RNAs and chromatin modifying enzymes contributes to the transition between epigenetic states in oligodendrocyte precursor cells, and could thereby lead to targeted therapies for illnesses such as multiple sclerosis.

Visit our research group's webpage: /en/mbb/goncalo-castelo-branco-group